J&J | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
AbbVie USD 3.32B 2.71B 2024-12
Abbott USD 49.06B 9.04B 2025-03
Amgen USD 6.21B 330M 2025-03
AstraZeneca USD 41.04B 168M 2025-03
Baxter International USD 6.96B 908M 2024-12
Bayer EUR 32.04B 1.49B 2024-12
Becton, Dickinson and Co. USD 25.24B 36M 2025-03
Biogen USD 16.98B 262.7M 2025-03
Boston Scientific USD 22.21B 443M 2025-03
Bristol-Myers Squibb USD 17.39B 1.05B 2025-03
CONMED USD 977.64M 14.96M 2025-03
Cooper Companies USD 8.13B 44.1M 2025-01
Dexcom USD 2.27B 164M 2025-03
Edwards Lifesciences USD 10B 452.8M 2024-12
Eli Lilly USD 15.85B 1.65B 2025-03
Gilead Sciences USD 19.33B 856M 2024-12
GlaxoSmithKline GBP 14.16B 486M 2025-03
Globus Medical USD 4.18B 107.94M 2024-12
Hologic USD 4.62B 154.6M 2025-03
Indivior -285000000 63M 2025-03
Insulet USD 1.21B 93.6M 2024-12
Integra LifeSciences USD 1.55B 23.69M 2024-12
Intuitive Surgical USD 17.21B 678.1M 2025-03
J&J USD 78.11B 6.62B 2025-03
Medtronic USD 49.39B 893M 2025-01
Merck USD 48.34B 2.02B 2025-03
Merit Medical Systems USD 1.43B 49.06M 2025-03
Novartis USD 44.05B 605M 2024-12
Pfizer USD 90.34B 2.14B 2025-03
Regeneron Pharmaceuticals USD 29.39B 34M 2025-03
Roche Holding CHF 36.16B 3.28B 2024-12
Sanofi 74.07B 3.78B 2025-03
Stryker USD 20.93B 296M 2025-03
Tandem Diabetes Care USD 155.29M 107.81M 2025-03
Teva Pharmaceutical Industries USD 6.26B 542M 2025-03
Vertex Pharmaceuticals USD 16.41B 778.7M 2024-12
Zimmer Biomet Holdings USD 12.47B 93.4M 2024-12
Zoetis USD 4.66B 115M 2025-03



J&J Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.